PCVX short interest
Vaxcyte Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 17,290,712 |
|---|---|
| Change vs prior report | 1,158,192 (+7.2%) |
| Change over six months | +26.3% |
| Days to cover | 11.39 (sector: 3.78) |
| Average daily volume | 1,517,422 |
| Rank in Healthcare | #79 of 922 by days to cover |
PCVX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 17,290,712 | +7.2% | 11.39 | 1,517,422 |
| 2026-09-15 | 16,132,520 | +7.4% | 13.04 | 1,236,803 |
| 2026-08-31 | 15,016,514 | +1.5% | 15.86 | 947,052 |
| 2026-08-14 | 14,796,265 | +2.3% | 15.85 | 933,368 |
| 2026-07-31 | 14,464,951 | +1.6% | 14.82 | 976,182 |
| 2026-07-15 | 14,231,919 | -18.5% | 12.37 | 1,150,360 |
| 2026-06-30 | 17,468,070 | +19.4% | 6.91 | 2,527,630 |
| 2026-06-15 | 14,629,103 | +1.1% | 10.73 | 1,363,059 |
| 2026-05-29 | 14,473,801 | +5.0% | 8.85 | 1,635,319 |
| 2026-05-15 | 13,789,778 | -2.5% | 7.75 | 1,778,976 |
| 2026-04-30 | 14,143,473 | -1.5% | 13.09 | 1,080,727 |
| 2026-04-15 | 14,356,548 | +4.9% | 11.75 | 1,221,940 |
| 2026-03-31 | 13,685,643 | +4.7% | 9.77 | 1,400,092 |
| 2026-03-13 | 13,067,798 | -1.4% | 10.89 | 1,200,307 |
| 2026-02-27 | 13,257,134 | -3.6% | 10.72 | 1,236,961 |
| 2026-02-13 | 13,755,621 | +15.1% | 7.85 | 1,751,323 |
| 2026-01-30 | 11,953,116 | -1.2% | 7.51 | 1,591,696 |
| 2026-01-15 | 12,095,806 | +1.6% | 12.49 | 968,645 |
| 2025-12-31 | 11,905,942 | +10.0% | 9.81 | 1,214,209 |
| 2025-12-15 | 10,827,314 | +5.1% | 6.62 | 1,634,980 |
| 2025-11-28 | 10,301,208 | +10.3% | 7.67 | 1,342,585 |
| 2025-11-14 | 9,336,796 | +8.9% | 6.34 | 1,472,299 |
| 2025-10-31 | 8,574,767 | -14.4% | 6.57 | 1,305,648 |
| 2025-10-15 | 10,013,969 | -9.6% | 4.79 | 2,090,752 |
| 2025-09-30 | 11,081,540 | -2.4% | 4.97 | 2,231,666 |
import finzdata as yf
yf.Ticker("PCVX").short_interest # every report since 2017
yf.Client().short_interest(["PCVX"], start="2018-01-01")Healthcare short interest · PCVX price history · Who owns PCVX · All short interest